Keyword: Veritas Genomics
Nebula will enable people to directly, anonymously sell their data to drug developers using a blockchain-enabled peer-to-peer network.
The takeover combines two George Church, Ph.D., cofounded startups to create a company equipped to sequence and make sense of genomes at scale.
Veritas Genetics picked up $30 million in Series B funding, which it will put toward expanding its product portfolio and operations, improving its consumer digital experience and building partnerships with hospitals and researchers worldwide.
For that price, which is less than the $1000 figure that was the industry's holy grail for years, Veritas is providing interpretation and genetic counseling, as well as whole genome sequencing.